| Draper Rehabilitation And Care Center | |
| 12702 South Fort Street, Draper, Utah 84020 | |
| (801) 571-2704 | |
| Name | Draper Rehabilitation And Care Center |
|---|---|
| Location | 12702 South Fort Street, Draper, Utah |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 93 |
| Occupancy Rate | 59.57% |
| Medicare ID (CCN) | 465091 |
| Legal Business Name | Beaver Valley Hospital |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1023215373 |
| Organization Name | SOUTH VALLEY HEALTHCARE, INC. |
| Doing Business As | DRAPER REHABILITATION AND CARE CENTER |
| Address | 12702 Fort St, Draper, UT 84020 |
| Phone Number | 801-571-2704 |
News Archive
Small non-coding RNA molecules, called microRNAs (miRNAs), found and measured in the blood plasma of asymptomatic pregnant women may predict development of preeclampsia, a condition characterized by high blood pressure and abnormal kidney function that affects roughly 5 to 8 percent of all pregnancies.
A new partnership between The Cancer Institute of New Jersey, the state's only National Cancer Institute -designated Comprehensive Cancer Center, and the New Jersey Department of Health and Senior Services will create a Center of Excellence for Cancer Surveillance to help track, examine, prevent and control cancer. CINJ is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.
BioCryst Pharmaceuticals, Inc. announced the presentation of data related to intravenous (i.v.) peramivir for the treatment of influenza at the 48th Annual Infectious Diseases Society of America (IDSA) meeting being held in Vancouver, Canada.
Shire plc, the global specialty biopharmaceutical company, announces that its subsidiary Shire Pharmaceuticals Inc. received a ruling from the FDA on its Citizen's Petition relating to Pentasa.
Life Technologies Corporation today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic™ Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.
› Verified 1 days ago
| NPI Number | 1417032608 |
| Organization Name | LANORES NURSING HOME, INC. |
| Doing Business As | DRAPER REHABILITATION & CARE CENTER |
| Address | 12702 Fort St, Draper, UT 84020 |
| Phone Number | 801-571-2704 |
News Archive
Small non-coding RNA molecules, called microRNAs (miRNAs), found and measured in the blood plasma of asymptomatic pregnant women may predict development of preeclampsia, a condition characterized by high blood pressure and abnormal kidney function that affects roughly 5 to 8 percent of all pregnancies.
A new partnership between The Cancer Institute of New Jersey, the state's only National Cancer Institute -designated Comprehensive Cancer Center, and the New Jersey Department of Health and Senior Services will create a Center of Excellence for Cancer Surveillance to help track, examine, prevent and control cancer. CINJ is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.
BioCryst Pharmaceuticals, Inc. announced the presentation of data related to intravenous (i.v.) peramivir for the treatment of influenza at the 48th Annual Infectious Diseases Society of America (IDSA) meeting being held in Vancouver, Canada.
Shire plc, the global specialty biopharmaceutical company, announces that its subsidiary Shire Pharmaceuticals Inc. received a ruling from the FDA on its Citizen's Petition relating to Pentasa.
Life Technologies Corporation today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic™ Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.
› Verified 1 days ago
| NPI Number | 1649621707 |
| Organization Name | BEAVER VALLEY HOSPITAL |
| Doing Business As | DRAPER REHABILITATION AND CARE CENTER |
| Address | 12702 S Fort St, Draper, UT 84020 |
| Phone Number | 801-571-2704 |
News Archive
Small non-coding RNA molecules, called microRNAs (miRNAs), found and measured in the blood plasma of asymptomatic pregnant women may predict development of preeclampsia, a condition characterized by high blood pressure and abnormal kidney function that affects roughly 5 to 8 percent of all pregnancies.
A new partnership between The Cancer Institute of New Jersey, the state's only National Cancer Institute -designated Comprehensive Cancer Center, and the New Jersey Department of Health and Senior Services will create a Center of Excellence for Cancer Surveillance to help track, examine, prevent and control cancer. CINJ is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.
BioCryst Pharmaceuticals, Inc. announced the presentation of data related to intravenous (i.v.) peramivir for the treatment of influenza at the 48th Annual Infectious Diseases Society of America (IDSA) meeting being held in Vancouver, Canada.
Shire plc, the global specialty biopharmaceutical company, announces that its subsidiary Shire Pharmaceuticals Inc. received a ruling from the FDA on its Citizen's Petition relating to Pentasa.
Life Technologies Corporation today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic™ Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Small non-coding RNA molecules, called microRNAs (miRNAs), found and measured in the blood plasma of asymptomatic pregnant women may predict development of preeclampsia, a condition characterized by high blood pressure and abnormal kidney function that affects roughly 5 to 8 percent of all pregnancies.
A new partnership between The Cancer Institute of New Jersey, the state's only National Cancer Institute -designated Comprehensive Cancer Center, and the New Jersey Department of Health and Senior Services will create a Center of Excellence for Cancer Surveillance to help track, examine, prevent and control cancer. CINJ is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.
BioCryst Pharmaceuticals, Inc. announced the presentation of data related to intravenous (i.v.) peramivir for the treatment of influenza at the 48th Annual Infectious Diseases Society of America (IDSA) meeting being held in Vancouver, Canada.
Shire plc, the global specialty biopharmaceutical company, announces that its subsidiary Shire Pharmaceuticals Inc. received a ruling from the FDA on its Citizen's Petition relating to Pentasa.
Life Technologies Corporation today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic™ Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 11.88 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.7 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 74.7 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.47 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 8.33 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.34 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 20.13 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.08 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 20.49 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.09 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.71 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 76.69 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 99.37 | 82.93 |
News Archive
Small non-coding RNA molecules, called microRNAs (miRNAs), found and measured in the blood plasma of asymptomatic pregnant women may predict development of preeclampsia, a condition characterized by high blood pressure and abnormal kidney function that affects roughly 5 to 8 percent of all pregnancies.
A new partnership between The Cancer Institute of New Jersey, the state's only National Cancer Institute -designated Comprehensive Cancer Center, and the New Jersey Department of Health and Senior Services will create a Center of Excellence for Cancer Surveillance to help track, examine, prevent and control cancer. CINJ is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.
BioCryst Pharmaceuticals, Inc. announced the presentation of data related to intravenous (i.v.) peramivir for the treatment of influenza at the 48th Annual Infectious Diseases Society of America (IDSA) meeting being held in Vancouver, Canada.
Shire plc, the global specialty biopharmaceutical company, announces that its subsidiary Shire Pharmaceuticals Inc. received a ruling from the FDA on its Citizen's Petition relating to Pentasa.
Life Technologies Corporation today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic™ Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.
› Verified 1 days ago
Draper Rehabilitation And Care Center Location: 12702 South Fort Street, Draper, Utah 84020 Phone: (801) 571-2704 |